-
Aclarion Announces Statistically Significant Nociscan Cost-Effectiveness Abstract Presented at ISASS Annual Meeting
[ad_1] Nociscan cost-effectiveness abstract highlights dominance over provocative discography and can save the US healthcare system $283M to $441M annually.…
Read More » -
News
Shibafrica Launches New Project, Combining Charity and Earning Opportunities
[ad_1] NEW YORK, NY – (NewMediaWire) – June 8, 2023 – Shibafrica is proud to announce the launch of their…
Read More » -
PaxMedica Enters Research Collaboration Agreement With PoloMar Health for Phase II Study in Autism Spectrum Disorder
[ad_1] Collaboration Will Investigate a Next Generation Orally Delivered Anti-Purinergic Compound Proof-of-Concept Study Based on one of PaxMedica’s Proprietary Pipeline…
Read More » -
News
Tesla, Rivian, Lucid, Ford, and GM Stocks All Outperformed by E-Cite Motors in Returns to Investors Over Past 2 Years, 1 Year, and 90 Days
[ad_1] BOTHELL, WA – (NewMediaWire) – June 8, 2023 – VaporBrands International, Inc. (OTC:VAPR) dba E-Cite Motors Group’s stock has outperformed…
Read More » -
News
Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease
[ad_1] – Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing multiple therapeutic programs intended to…
Read More »